TR

  • Personnel Profile | Academic

Cover Image
profile_image

Prof. Dr. Mümtaz İŞCAN

Faculty of Pharmacy/Pharmacy
Download Contact
E-mail:
miscan@ciu.edu.tr
Phone No:
+90 392 671 11 11
Extension:
2661
Office:
ST244
Ankara

Eczacılık (Undergraduate , 1975)

Ankara

Toxicology (PhD , 1982)

  • The investigation of the effects of nickel on mouse liver mixed function oxidase enzyme system - 1987
  • The investigation of the effects of cigarette smole on rat liver and lung xenobiotic metabolizing enzymes - 1987
  • The combined effects of cadmium and nickel on rat and guinea pig monoxygenases and glutathione conjugation enzymes - 1990
  • The monitoring of the Van lake pollution by measuring fish cytochrome P-450 and glutathione S transferase enzyme activites as biological indicator. - 1997
  • The role of EROD activity in development of human breast cancer related with chemical carcinogens - 1997
  • The investigation of the expression and localization of CYP1A1 and CYP1B1 which play role in development of breast cancer in normal and neoplastic breast tissue cells - 1998
  • The investigation of the role of metabolic polymorphism on the individual sensitivity to polycyclic aromatic hydrocarbons - 2001
  • The role of metabolic (GSTP1) polymorphism in drug resistance in lung cancer - 2006
  • The role of metabolic (CYP1) polymorphism in drug resistance in lung cancer - 2007
  • The investigation of the GST Omega 1 (A140D) gene polymorphism in some individuals of Turkish population - 2008
  • The role of metabolic (CYP2E1) polymorphism in drug resistance in lung cancer - 2010
  • The role of metabolic (CYP1B1) polymorphism in drug resistance in lung cancer - 2015
  • he role of metabolic (CYP3A4) polymorphism in drug resistance in lung cancer - 2017
  • Assessment of the serum periostin, tenascin-C, eopterin, YKL-40 and indolamin levels in asbest related malign mesotelioma. - 2019
  • The investigation of the activites of antioxidant enzymes in breast carcinomas - 1992
  • The effects of benzimidazol compounds having retinodial acitivity on free radicals and lipid peroxidation - 1996
  • The role of EROD (CYP1A1) enzyme activity on human breast cancer - 1997
  • The investigation of the combined effects of cadmium and nickel on rat lung and kidney cytochrome P450 enzyme system which play role in bioactivation of xenobiotics - 1998
  • Molecular Toxicology
  • Risk Assessment of chemicals
    Master Thesis Supervised

  • The investigation of the effects of nickel on mouse liver mixed function oxidase enzyme system

  • Interindividual variability of coumarin 7-hydroxylation in a Turkish population.

  • Investigation of lipid peroxidation levels in breast tumors

  • Investigation of the ethoxyresorufin O-deethylase enzyme activity in breast cancer

  • The effects of cadmium and nickel on rat testis xenobiotic metabolism

  • The clinical significance of interactions of warfarin, carbamazepin and amitriptilin interaction at metabolism level

  • The role of metabolic (GSTP1) polymorphism in lung cancer

  • The interactions of calcium channel blokers at metabolism level and the importance of CYP3A4

  • The role of metabolic (CYP1) polymorphism in drug resistance in lung cancer

  • The investigation of the GSTP1 gene polymorphism in some individuals of Turkish population

  • The investigation of the GST Omega 1 (A140D) gene polymorphism in some individuals of Turkish population

  • The role of metabolic (CYP1B1) polymorphism in drug resistance in lung cancer

  • The role of metabolic (CYP3A4) polymorphism in drug resistance in lung cancer

    • Doctorate Thesis Supervised

  • The investigation of the effects of cigarette smole on rat liver and lung xenobiotic metabolizing enzymes

  • The investigation of the antioxidant enzymes in breast carcinomas

  • The investigation of the role of metabolic polymorphism on the individual sensitivity to polycyclic aromatic hydrocarbons

  • The role of metabolic polymorphism in drug resistance in lung cancer

  • The role of metabolic (CYP2E1) polymorphism in drug resistance in lung cancer

  • The role of metabolic (mEH) polymorphism in drug resistance in lung cancer

  • Assessment of the serum periostin, tenascin-C, eopterin, YKL-40 and indolamin levels in asbest related malign mesotelioma